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Abstract
Background: Since the isolation of Helicobacter species in biliary system, a hypothetical question was raised about the role
of these agents in the development of cholelithiasis. This meta-analysis is to explore the association between the
Helicobacter infection and biliary lithiasis.
Methodology/Principal Findings: A systematic literature search was performed to identify all eligible articles. Meta-analysis
which was carried out using odds ratio and random effect model, 95% confidence intervals for odds ratio was calculated.
Quantitative assessment of heterogeneity was explored by chi-square test with significance set at P value 0.10 and was
measured using I
2 statistic. Eighteen studies published between 1998 and 2011 were finally eligible for meta-analysis. H.
Pylori, H. Bilis, H. Hepaticus, H. Pullorum and H. Ganmani were studied. With heterogeneity (I
2=69.5%, P,0.0001),
significantly higher pooled infection rates of H. Pylori (OR: 2.59, 35.82% versus 26.75%, P=0.01) and H. Hepaticus (OR: 3.13,
31.30% versus 12.12%, P=0.02) were observed in lithiasis group. Higher prevalence of H. Pylori in cholelithiasis patients
were reported by studies from East Asia, South Asia and South America. Evidences supporting the higher presence of H.
Pylori in cholelithiasis patients could be found by PCR for detecting 16s rRNA in bile, 26kDa protein gene in biliary tissue and
immunohistochemistry. Using multiple detection tests could increase the detection rate of H. Pylori.
Conclusions/Significances: Our meta-analysis suggests a trend of higher presence of H. Pylori in cholelithiasis patients than
control group and this trend was significant in the regions with higher prevalence of this agent. Evidences supporting the
association between Helicobacter and cholelithiasis could be found by using different tests but the gold standard for the
identification of these bacteria in biliary system has yet to be established. Considering obvious heterogeneity, a large multi-
center study will facilitate us to further clarify the association between the Helicobacter infection and cholelithiasis.
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Introduction
Helicobacter Pylori (H. Pylori), classified as a type I carcinogen, is
proved to be the main pathogen responsible for chronic gastritis,
gastroduodenal ulcers and gastric carcinoma [1]. Besides this most
well-known member, more than 20 other Helicobacter species
(Helicobacter sp.) have been identified and several of them are
associated with various chronic digestive diseases [2–4]. Biliary
lithiasis is one of the most common conditions requiring surgical
management. Although its pathogenesis still remains obscure,
chronic infection is already accepted as a potential risk factor [5].
In the past decade, with continuous isolation of H. Pylori, H. Bilis,
H. Hepaticus and other Helicobacter sp. in bile, biliary tract tissue and
stone specimens [6], a hypothetical question was raised about the
role of these infectious agents in the development of biliary
lithiasis.
However, studies carried out so far failed to establish association
between the colonization of Helicobacter sp. in biliary tract and
stone diseases. Some reported strong positive correlation while
others indicated totally negative results [7–9]. To understand these
controversial findings, the following three premises should be
concerned. Firstly, most studies on this issue were observational
reports without control groups. When it comes to case-control
studies, many of them have involved either small sample size of
lithiasis patients, or even smaller members of controls [10,11].
Insufficient sample size may not have enough power to distinguish
the differences between the two groups. Secondly, discordant
results may be due to the geographic distribution variations of
Helicobacter species. Epidemiologically, The prevalence of H. Pylori
in East Asian countries is significantly higher than in western
countries [12]. Investigators from Taiwan obtained DNA
fragments of Helicobacter sp. in patients with extrahepatic biliary
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German failed to achieve comparable results using the same
detecting method [13–15]. Moreover, various techniques are
utilized for identify Helicobacter species. Among them, PCR is the
most common used means for detecting 16s rRNA, the genes
encoding the H. Pylori-specific 26kDa protein, urease A, Vac A
and Cag A proteins. Besides PCR, many data available also have
relied on culture, immunohistochemistry staining (IHC), fast
urease test (FUT) and enzyme-linked immunosorbent assay
(ELISA) [16,17]. However, the detection rates of Helicobacter sp.
vary between the above methods and they have not been
comprehensively measured or tracked yet.
Based on the current status of knowledge in this field, we
systematically review the published studies and present a meta-
analysis to explore whether there is an association between the
Helicobacter sp. infection and biliary lithiasis formation.
Materials and Methods
Literature Search
We followed QUOROM guidelines [18] for conducting meta-
analysis and the study design and report adhered to the PRISMA
Statement guidelines (supporting information Table S1). Two
investigators (DZ and YZ) performed a systematic literature search
independently by using Pubmed, Embase, ISI databases and the
Cochrane Library Central between January 1980 and June 2011
at different time and at two different medical science information
centers respectively affiliated to FuDan University and Shanghai
JiaoTong University. The search was limited to humans. The
search strategy was based on the following Medical Subject
Heading terms (MeSH) and text words: "hepatobiliary", "biliary",
"biliary tract", "gallbladder", "biliary duct", "lithiasis", "stone",
"stone disease", "calculi", "gallstones", "cholelithiasis", "choledo-
cholithiasis", "cholecystolithiasis", "gallbladder stone", "common
bile duct stone", "helicobacter", "Helicobacter Pylori", "Helicobacter
Bilis", "Helicobacter Hepaticus", "Helicobacter Pullorum", "Hp", "H.
Pylori", "H. Bilis", "H. Hepaticus", "H. Pullorum", "H. Ganmani",
"Helicobacter species", "Helicobacter sp. ", "Helicobacter genus" and
"case-control". The related articles function and reference lists
were used to broaden the search. The investigators and experts in
this field ensured that all potentially relevant reports were
identified. The search was limited to humans. No restriction was
set for languages or date of publication. When further information
was required, the corresponding authors of relevant papers were
contacted by the reviewers.
Data Extraction
The above two investigators performed the data extraction
independently and in the case of discrepancy, the decision was
made by discussion or in consultation with a third author (XFW).
A data extraction was carried out to record details of first and
correspondent authors, year and country of publication, study
type, method of detection, diagnosis, type of specimen, sample size
and type of organism identified. The numbers of Helicobacter-
positive and negative patients in lithiasis group and control group
were collected. The number of the relevant patients was extracted
for the subgroup analysis stratifying by Helicobacter species,
geographic regions, types of detecting methods and types of
specimens.
Inclusion Criteria
1. Study design: published case-control study provide raw data
dealing with Helicobacter-sp. infection in both human lithiasis
group and control group.
2. Helicobacter-sp. infection had to be confirmed by polymerase
chain reaction (PCR), culture, immunohistochemistry staining
(IHC), fast urease test (FUT) and enzyme-linked immunosor-
bent assay (ELISA). At least one positive test was regarded as
confirmation of infection.
Exclusion Criteria
1. Case report and observational studies without control groups.
2. Studies in which the raw data of Helicobacter-sp. infection rates
were not available in either lithiasis cases group or control
group.
3. Studies limited to animals.
Statistical Analysis
Calculation for dichotomous variables was carried out using the
odds ratio (OR) and their 95% CI as the summary statistic. The
Mentel-Haenszel method was used to combine OR for the
outcome parameters. Yate’s correction was performed for studies
containing a ‘‘zero’’ in one cell for the number of positive cases in
one of the two groups [19].
Owing to the between-study variability of sample size and
detection methods, overall estimates were calculated by using the
random effect models [20]. Quantitative assessment of heteroge-
neity was explored by chi-square test with significance set at P
value 0.10 and was measured using I
2 statistic. The larger is the
value, the greater is the heterogeneity. Graphical test with Begg’s
funnel plot was used to detect the publication bias [21]. A two-
sided P value less than 0.05 was considered statistically significant.
The software SAS 9.13 (SAS Institute, Gary, North Carolina),
Review Manager version 4.2 (Cochrane Collaboration, Software
Update, Oxford), Intercooled Stata version 7.0 for Windows (Stata
Corporation, USA) were used for conducting this meta-analysis.
Results
Description of Studies
Both of the two investigators agreed on the result of data
extraction. The strategy of study selection is displayed in Figure
S1. Eighteen case-control studies published between 1998 and
2011 were finally eligible for meta-analysis (Table 1) [8,9,22–37].
These studies involved 1678 patients with a total Helicobacter sp.
infection rate of 30.39% (510/1678). The cumulative sample size
of biliary lithiasis group was 1071 of which 364 were positive
(33.39%) while of 607 controls only 146 (24.05%) were positive for
Helicobacter infection.
In the 18 included studies, six were from East-Asian countries,
one from South Asia (Pakistan), three from Middle East, one from
Oceania (New Zealand), six from Europe and one from South
America (Brazil). Totally 5 species of Helicobacter including H.
Pylori, H. Bilis, H. Hepaticus, H. Pullorum and H. Ganmani were
studied [9,26,31,32,35,36]. H. Pylori was still the commonest
species which was identified in 13 studies (Table 2). As for
detecting methods, fourteen studies used PCR for 16s rRNA while
two and three studies used that for H. Pylori-specific 26kDa protein
and urease A. Besides PCR, culture, immunohistochemistry and
ELISA were performed in six, three and four studies, respectively.
All of the 18 included studies were approved by the Ethics
Committee of their respective institute and informed consents
were obtained from all patients before their enrolling in the
studies. No publications for the assessment of social or ethical
issues could be found.
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Thirteen studies were focused on H. Pylori [8,22,24,25,27–
31,33–35,37]. Regardless of various detecting methods, a
significantly higher infection rate was noted in lithiasis group than
control group (35.82% versus 26.75%, Z=2.45, P=0.01). With
heterogeneity (I
2=69.5%, P,0.0001), the cumulative odds ratio
for the sample was 2.59 (95% CI 1.21–5.55) and favored the role
of H. Pylori in lithiasis cases (Figure 1). A sensitivity analysis
omitting 1 study at a time and calculating the pooled ORs for the
remainder of the studies showed that the two study by Yucebilgili
[34] and Figura [22] might substantially influence the pooled OR.
After excluding these two studies, there was no heterogeneity
Table 1. Characteristics of studies on Helicobacter sp. in cholelithiasis patients and control group.
Reference
(year) Country
Method of
Detection Disease Specimen
Organism
identified
Helicobacter sp. (+)
in lithiasis Group
n/N
Helicobacte sp. (+)
in Control Group
n/N
Figura (1998) Italy ELISA (H.Pylori IgG) Cholecystolithiasis Serum H.Pylori 92/112 90/112
Myung (2000) Korea ELISA (H.Pylori IgG)
PCR (Urea A, 26KD
protein) IHC
Hepatolithiasis,
Choledocholithiasis
Serum, Bile,
Biliary Tissue,
Stone
H.Pylori 7/30 0/8
Leong (2001) China PCR (16sRNA) Choledocholithiasis Bile Helicobacter sp. 4/25 0/4
Lo ¨hr (2002) Yugoslavia PCR (16sRNA) Cholecystolithiasis Bile H.Pylori 37/63 3/11
Bulajic (2002) Yugoslavia PCR (Urea A) Cholelithiasis Bile H.Pylori 26/48 1/7
Matsukura (2002) Japan PCR (16sRNA) Cholecystolithiasis Bile H.bilis 18/42 4/14
Presser Silvar
(2003)
Brazil PCR (16sRNA)
Culture
Cholelithiasis Bile, Biliary
Tissue
H.Pylori 28/51 2/18
Chen (2003) New Zealand PCR (16sRNA, 26KD
protein) ELISA
(H.Pylori IgG)
Cholecystolithiasis GB Tissue,
Bile, Serum
H.Pylori 35/70 15/37
Farshad (2004) Iran PCR (16sRNA) Cholecystolithiasis Stone, Bile H.Pylori 10/33 0/40
Abayli (2005) Turkey PCR (16sRNA) IHC
Culture
Cholecystolithiasis Stone, GB
Tissue
H.Pylori 18/77 0/20
Kobayashi (2005) Japan PCR (16sRNA, Urea A)
Culture
Cholelithiasis Bile H.Pylori, H.bilis 15/30 1/30 2/21 0/21
Bohr (2007) Germany PCR (16sRNA) IHC
Culture
Cholecystolithiasis GB Tissue H. ganmani 1/57 0/22
Hamada (2009) Japan PCR (16sRNA) Culture Cholelithiasis Bile H.hepaticus 25/60 4/32
Griniatsos (2009) Greece PCR (16sRNA) Cholecystolithiasis GB Tissue H.Pylori 4/89 2/42
Yucebilgil (2009) Turkey PCR (16sRNA) Culture Cholelithiasis GB Tissue H.Pylori 2/41 13/27
Karagin (2010) Sweden PCR (16sRNA) Cholecystolithiasis GB Tissue H.Pylori, H.
pullorum
1/100 6/100 0/102 0/102
Shimoyama
(2010)
Japan ELISA (H.hepaticus IgG) Cholelithiasis Serum H.hepaticus 11/55 4/34
Yakoob (2011) Pakistan PCR (16sRNA) IHC Cholelithiasis Biliary Tissue H.Pylori 23/88 6/56
ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction; RNA: ribonucleic acid; IHC: immunohistochemistry; Urea A: Urease A; GB: gallbladder.
doi:10.1371/journal.pone.0027390.t001
Table 2. Meta-analysis on the prevalence of Helicobacter species in cholelithiasis group compared with control group.
Subgroup
No. of
Studies
Helicobacter sp. (+)i n
lithiasis Group n/N
Helicobacter sp. (+) in Control
Group n/N OR (95% CI) p value
Helicobacter Species
H. Pylori 13 298/832 134/501 2.59 (1.21, 5.55) 0.01
*
H. Bilis 2 19/72 4/35 1.92 (0.57, 6.46) 0.29
H.Hepaticus 2 36/115 8/66 3.13 (1.20, 8.19) 0.02
*
H.Ganmani 1 1/57 0/22 1.19 (0.05, 30.43) 0.91
H.Pullorum 1 6/100 0/102 14.10 (0.78, 253.71) 0.07
OR, odds ratio; CI, confidence interval;
D: p,0.01;
*: p,0.05.
doi:10.1371/journal.pone.0027390.t002
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influential factors that may impact the overall results. The
potential differences in various detecting methods, types of
specimens and geographic distribution are the most important
concerns.
Four techniques including ELISA [8,22,28], PCR [8,24,25,27–
31,33–35,37], immunohistochemistry staining (IHC) [30,37] and
culture [27,30,31,34] were utilized for identifying the presence of
H. Pylori (Table 3). ELISA was performed in three studies in order
to detect the H. Pylori-specific IgG in serum samples. The pooled
data showed that the positive rate of this antibody was similar
between the lithiasis group and control group (67.38% versus
69.33%, OR: 1.01, 95% CI: 0.58–1.75, P=0.97). Because PCR is
the most widely used method and different primers may vary in
sensitivity and specificity, we analyzed the results based on 16s
rRNA, 26kDa protein and urease A genes (Table 3). Two studies
by Farshad [29] and Abayli [30] reported that 16s rRNA was
found in biliary stones. In bile specimens, the pooled OR of 16s
rRNA was 6.74 (95% CI: 2.55–17.83), indicating a significantly
higher detection rate in cholelithiasis patients than control group
(42.33% versus 7.04%, P=0.000). When using the primer of
urease A, subgroup analysis also revealed a higher presence of
30.54% (51/167) in lithiasis group than that of 16.67% (6/36) in
control group, but the difference was not statistically significant
(OR: 1.63, 95% CI: 0.64–4.15, P=0.31). Besides bile, detection
was also performed in gallbladder and biliary tract epithelium
(Table 3). The ORs of 16s rRNA and 26kDa protein were
respectively, 1.39 (95% CI: 0.90–2.16, P=0.14) and 2.48 (95%
CI: 1.05–5.84, P=0.04), indicating that more 26kDa protein was
detected in lithiasis group. Notably, immunohistochemistry
staining (IHC) supported the higher presence of H. Pylori in
lithiasis group than controls (15.17% versus 5.95%, OR: 3.79,
95% CI: 1.43–10.04, P=0.007). In addition, five studies utilized
bile, gallbladder and biliary duct tissues for culture
[27,28,30,31,34]. Unfortunately, from bile specimens, no grown
spiral shaped Gram-negative bacteria could be observed by
microscopy and only 3.02% (6/199) of the tissue samples from
biliary lithiasis were positive for H. Pylori. Although the above
subgroup analysis revealed great differences, the pooled result of
various detection methods showed that the prevalence of H. Pylori
was significantly higher in lithiaisis group than control group did
not change.
Among the 13 included studies focused on H. Pylori, six studies
used only one diagnostic test (five used PCR and one used ELISA)
while the remaining 7 performed two or more different tests
(Table 1). The total detection rate of H. Pylori might not only
depend on the detection technology itself, but also affected by how
many tests were utilized in each study. Therefore, we conducted
the subgroup analysis stratified by studies in which only one test
was H. Pylori-positive and at least two tests were H. Pylori-positive.
Finally, as showed in Table 3, there were 5 studies in which at least
two different tests were positive for H. Pylori and subgroup analysis
of them indicated a significantly higher total detection rate of H.
Pylori (33.22% versus 16.20%, P=0.004) in the lithiasis group than
control group (without double counting the same patients who
were positive in different tests). Conversely, analysis of studies in
which only one test was H. Pylori-positive showed comparable
detection rates between the two groups (37.24% versus 30.92%,
P=0.22). However, according to these data, the detection rate of
studies in which only one test was H. Pylori-positive (37.24% in
lithiasis group and 30.92% in control group, respectively) was
relatively higher than that of studies in which at least two tests
were positive (only 33.22% in lithiasis group and 16.20% in
control group, respectively). The possible explanation for this
result might be due to the type of diagnostic technology and
specimen. In the study by Figura [22], ELISA was performed to
detect the H. Pylori-IgG in serum samples and the detection rates
in the lithiasis and control group were 82.14% (92/112) and
80.36% (90/112), respectively. Considering that only detecting
IgG in serum might not reflect the real infectious state of H. Pylori
in biliary system, we conducted further subgroup analysis after
excluding this study. Finally, in studies which only one test was H.
Pylori-positive, the overall result did not change (P=0.26) but the
detection rates were decreased to 25.41% (108/425) in lithiasis
group and 8.50% (21/247) in control group, respectively (Table 3).
Stratifying by geographic region, the ORs were 8.35 (95% CI
2.01–34.69) for 2 studies conducted in East Asia [8,31], 2.95 (95%
CI 1.12–7.79) for 1 study from Pakistan [37] and 9.74 (95% CI,
Figure 1. Meta-analysis of studies on the prevalence of H.Pylori in cholelithiasis group compared with control group.
doi:10.1371/journal.pone.0027390.g001
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regions were able to confirm significantly higher infection rates of
H. Pylori in lithiasis group than control group (P=0.003, 0.03 and
0.004, respectively). In contrast, investigators from Middle East
[29,30,34], New Zealand [28] and Europe [22,24,25,33,35] could
not find any difference of H. Pylori presence between the two
groups (P=0.69, 0.35 and 0.12, respectively) (Table 3).
Prevalence of other Helicobacter sp. in biliary lithiasis
group and control group
Besides H. Pylori, the pooled prevalence of H. Hepaticus in 2
studies was also much higher in lithiasis group (31.30% versus
12.12%, P=0.02) [32,36]. Regarding H. Bilis, conversely, analysis
of 2 studies did not show any difference between the two groups
(26.39% versus 11.43%, P=0.29) [26,31]. In addition, there was
one study concerning H. Ganmani and another one on H. Pullorum,
either demonstrated similar positive rates between the lithiasis and
controls (P=0.91 and 0.07, respectively) [9,35]. Unfortunately, we
could not conduct further analyses stratified by geographic
distribution, detecting methods or types of specimens because
only one or two studies reported results of each of these 4 species.
Publication Bias
The funnel plot did not show evidence of publication bias
(Begg’s test z=0.73, P=0.466, continuity corrected). (Figure 2).
Discussion
The relationship between the Helicobacter infection and chole-
lithiaisis still remains controversial. Some studies have supported a
cause-and-effect association while some others even failed to
confirm the existence of these bacteria in biliary specimens [7–10].
Also, there is a lack of strong evidences to determine the possible
entry routes of Helicobacter sp. to the hepatobiliary tree including
either the ascending duodenum infection or the portal system
circulation pathway [38,39]. Till now, we do not know exactly
which Helicobacter sp. are to be found in human biliary lithiasis
disease and what’s the best way to identify their colonization.
Among various Helicobacter species, H. Pylori still remains the most
studied one whose prevalence ranges from 60 to 80% in patients
withgastric ulcer and 90–100% in those withduodenal ulcer [1,40].
In this meta-analysis, a significantly higher presence of H. Pylori was
observed in lithiasis group than control group (35.82% versus
Table 3. Subgroup analysis on the prevalence of H.Pylori in cholelithiasis group compared with control group.
Subgroup
No. of
Studies
H. Pylori (+) in lithiasis
Group n/N
H. Pylori (+) in Control
Group n/N OR (95% CI) p value
Geographic Distribution
East Asia 2 22/60 2/29 8.35 (2.01, 34.69) 0.003
D
South Asia 1 23/88 6/56 2.95 (1.12, 7.79) 0.03
*
Middle East 3 30/151 13/87 2.61 (0.03, 272.54) 0.69
Oceania 1 35/70 15/37 1.47 (0.65, 3.28) 0.35
Europe 5 160/412 96/274 1.72 (0.86, 3.43) 0.12
South America 1 28/51 2/18 9.74 (2.03, 46.81) 0.004
D
Detecting Methods and Specimens
Serum
ELISA (H. Pylori-Ig G) 3 126/187 104/150 1.01 (0.58, 1.75) 0.97
Bile
PCR (16s rRNA) 4 69/163 5/71 6.74 (2.55, 17.83) 0.000
D
PCR (Urease A) 3 51/167 6/36 1.63 (0.64, 4.15) 0.31
Culture 2 0/67 0/20 N/A N/A
Biliary Tissue
PCR (16s rRNA) 8 93/562 38/310 1.39 (0.90, 2.16) 0.14
PCR (26kDa protein) 2 26/123 8/67 2.48 (1.05, 5.84) 0.04
*
Culture 4 6/199 0/86 3.73 (0.20, 68.97) 0.38
IHC 3 32/211 5/84 3.79 (1.43, 10.04) 0.007
D
The Number of H. Pylori (+) Tests (including
the study by Figura)
Only 1 test was H. Pylori (+) 8 200/537 111/359 2.12 (0.63, 7.15) 0.22
At least 2 tests were H. Pylori (+) 5 98/295 23/142 3.18 (1.44, 7.00) 0.004
D
The Number of H. Pylori (+) Tests (excluding
the study by Figura)
Only 1 test was H. Pylori (+) 7 108/425 21/247 2.54 (0.50, 12.88) 0.26
At least 2 tests were H. Pylori (+) 5 98/295 23/142 3.18 (1.44, 7.00) 0.004
D
ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction; RNA: ribonucleic acid; Urea A: Urease A; IHC: immunohistochemistry; OR, odds ratio; CI,
confidence interval;
D: p,0.01;
*: p,0.05.
doi:10.1371/journal.pone.0027390.t003
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bacterial infection and lithiasis. However, when regarding each
included study, although most of them reported a higher prevalence
of H. Pylori in lithiasis group, only five reached the significant level
[27,29,31,32,37]. The small sample size might be one of the
explanations for the negative results.
At present, PCR, culture, immunohistochemistry and ELISA
are the most widely used techniques for detecting Helicobacter sp. In
our meta-analysis, a wide rage of detection rates vary from 3.02%
to 80% was observed owing to different methods and types of
specimens. ELISA is an inexpensive and easy test on serum
samples to determine the infectious state of H. Pylori. However,
because of the limitation to the specificity in confirming species
and subspecies due to cross-reactivity of the Helicobacter and
Campylobacter, no strong correlation could be established yet
between the presence of Helicobacter specific-IgG in serum and
the presence of H. Pylori in biliary system [28,41]. PCR is a highly
sensitive method which can selectively amplify the copies of a
target gene by more than 10
6-fold [42,43]. Recently, assays based
on PCR have been developed to detect the presence of H. Pylori
DNA by using several gene targets directly from the biopsies. The
targets include the 16s rRNA gene, urease A gene and the 26kDa
species-specific protein gene [44,45]. In this study, subgroup
analysis was carefully conducted and we found that diverse
sensitivities and specificities of these primers as well as the impact
of specimen type really contributed to the variation of the pooled
estimates (Table 3). The three primers all reported relatively
higher positive rates in lithiasis group than control group,
however, in bile, it was 16s rRNA reached significant level and
in biliary tissue 26kDa favored the role of H. Pylori in lithiasis
formation. (P=0.000 and 0.04, respectively). To explain the
greatly different results of 16s rRNA between bile and tissue
samples, the existed finding suggested that Helicobacter species
relatively less colonize in biliary epithelium [46]. Among the three
primers, urease A may cross-react with the urease gene of other
organisms so that PCR based on this primer may produce a false
positive result [47]. Therefore, many studies have utilized 16s
rRNA and 26kDa gene, which can respectively identify the entire
Helicobacter genus and the H. Pylori-specific subunit of urease rather
than being interfered by other species that can produce urease
[48]. Till now, only a few studies have confirmed the existence of
H. Pylori in biliary system by immunohistochemistry. The routine
hematoxylin-eosin stain is not well suited for H. pylori detection
because of the weak contrast between the bacteria and the mucus.
The Warthin-Starry stain provides a better visualization of the
bacteria, but the procedure is difficult to carry out. This technique
is time-consuming and requires instant preparation of the relevant
reagents [49]. Notably, meta-analysis of three studies using
Warthin-Starry stain demonstrated a higher presence of H. Pylori
in lithiasis group (P=0.007). Culture remains the definitive
method to prove the viability of H. Pylori. Unfortunately, our
study revealed that no grown H. Pylori from bile could be observed
and only 3.02% (6/199) of the tissue samples were positive in
cultivation of this bacterium. Why this occurs might be due to the
use of frozen bile as sample and the strongly inhibitory effects of
bile acid. Obviously, further research on exploring the optimal
conditions for growing H. Pylori in vitro is necessary. However, on
the other hand, since the results of many other kinds of molecular
biological tests favored the correlation between these Helicobacter
species and biliary lithiasis, whether only alive bacteria would
cause stone disease or the biological component of Helicobacter itself
is immunologically enough to be the initiator of evil for biliary
lithiasis is also worth further investigation. In addition, our findings
also suggested that performing multiple detection tests could
increase the detection rate of H. Pylori. Although PCR is the most
widely used technology for confirming the presence of H. Pylori
due to its highly sensitivity, the detection rate was 25.41% in
lithiasis group. Subgroup analysis of these studies showed that
using only one test might not have enough power to confirm the
relationship between the infection of H. Pylori and the biliary
lithiasis (P=0.26). In contrast, when performing at least two tests,
the detection rate increased to 33.22% in lithiasis group which was
significantly higher than that in control group (33.22% versus
16.20%, P=0.004).
The prevalence of Helicobacter pylori infection ranges widely
between nation and nation. In developing countries such as India,
Figure 2. Funnel plot to detect publication bias. s.e. represents standard error.
doi:10.1371/journal.pone.0027390.g002
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approximately 80% of the population by 20 years of age. In
contrast, this rate is as low as 10–20% in developed countries
[50,51]. The lower prevalence of H. Pylori in industrialized
countries is attributed to the higher hygiene and socioeconomic
standards [51]. In our meta-analysis, data showed a trend of
higher presence of H. Pylori in cholelithiasis patients than control
group and this trend was significant in the developing regions with
higher prevalence of this bacterium. Notably, Japan is a special
case. According to our study, although Japan is a developed
country which has a higher standard of environmental hygiene,
studies from this countries all reported relatively higher infection
rates of Helicobacter from 30% to 60% in lithiasis patients and each
indicated a strong correlation between the bacteria infection and
biliary lithiasis [26,31,32,36]. Based on browsing more literatures,
we found the possible explanations. Interestingly, the younger
generation in Japan have a similar infection rate as seen in
developed countries whereas the older generation has the higher
prevalence as seen in developing countries. For example, the
infection rate of H. pylori in children under 10 years old is less than
5% and it gradually increased to approximately 20% in people of
10–19 years old, 25% in those 20–29 years old, 40% in those 30–
39 years old and this rate is more than 60% at people of 50 years
old and over [52]. Why this occurs might be due to the fact that
higher standard of sanitary conditions such as clean public water
systems were introduced in Japan after the 1950s. In our meta-
analysis, the mean age of the biliary lithiasis patients of the studies
from Japan was 50–60 years old, which is in consistent with the
corresponding infection rate of the bacteria.
Besides H. Pylori, several other Helicobacter sp. including H.
Hepaticus, H. bilis H. Pullorum and H. Ganmani have also been shown
to be bile-tolerant and colonize the hepatobiliary system
[9,26,31,32,35,36]. Maurer et al reported that mice infected with
H. bilis or co-infected with H. Hepaticus developed cholesterol
gallstones at 80% prevalence compared with approximately 10%
in uninfected controls [53]. H. Ganmani and H. Pullorum were novel
enterohepatic Helicobacter species found in patients with cholestasis
and other chronic liver diseases [54,55]. In this meta-analysis,
studies on these four species all reported relatively higher positive
rates in lithiasis group than control group and this rate of H.
Hepaticus reached the significant level (P=0.02). Considering these
studies were limited by small sample sizes, it’s no doubt that
further research should be undertaken to determine their
association with cholelithiasis.
Regarding the limitations of this study, there was obvious
heterogeneity across the studies, which suggested a diversity of
study design may cause a disturbing impact on the results. Firstly,
there is a lack of gold standard for the selection of the controls.
Most of the studies involved patients with severe obesity or liver
transplantation donors as controls and from whom the gallbladder
and bile were obtained during routine cholecystectomy. However,
a couple of studies collected biliary samples from gastric cancer
patients. Considering the infection of H. Pylori is strongly linked to
the pathogenesis of gastric cancer and the ascending duodenum
pathway might be the possible entry route of the bacteria into the
hepatobiliary tree, whether the unknown infectious status of H.
Pylori in biliary tract of gastric cancer patients might affect the
comparison between the case and control groups needs further
observation. Secondly, for identifying the existence of Helicobacter,
some studies used only one detecting method while others used
several. This might result in reporting different cumulative positive
rates between studies and induce significant heterogeneity. Finally,
few studies mentioned whether they used antibiotics prior to
sample collection which might further inhibit the growth of the
organisms and produce a false negative result.
In conclusion, this meta-analysis revealed a trend of higher
presence of H. Pylori in cholelithiasis patients than control group
and this trend was significant in the regions with higher prevalence
of this infectious agent. Evidences supporting the association
between the H. Pylori infection and biliary lithiasis could be found
in either bile, biliary tissue or stone samples. Because sensitivity
and specifity differ greatly among various detecting techniques, the
gold standard for the identification of Helicobacter species in biliary
system has yet to be established. Besides H. Pylori, there have been
a couple of studies showing higher percentage of other Helicobacter
species in cholelithiasis patients, however, due to the limited
number of studies and their small sample sizes, further research
should be conducted to investigate their possible relationship.
Considering the obvious heterogeneity in our study, we encourage
carrying out large-scale and multicenter studies for clarifying the
association of Helicobacter species and biliary lithiasis diseases to
conclusion.
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